F

Fuan Pharmaceutical Group Co Ltd
SZSE:300194

Watchlist Manager
Fuan Pharmaceutical Group Co Ltd
SZSE:300194
Watchlist
Price: 4.67 CNY 0.65% Market Closed
Market Cap: ¥5.6B

Wall Street
Price Targets

Price Targets Summary
Fuan Pharmaceutical Group Co Ltd

There are no price targets for Fuan Pharmaceutical Group Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Fuan Pharmaceutical Group Co Ltd Competitors:
Price Targets
UUU
3U Holding AG
82% Upside

Revenue
Forecast

16% / Year
Past Growth
-3% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
16% / Year
Past Growth
-3% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 13 years the compound annual growth rate for Fuan Pharmaceutical Group Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is -3%.

Operating Income
Forecast

10% / Year
Past Growth
54% / Year
Estimated Growth
Estimates Accuracy
-44%
Average Miss
10% / Year
Past Growth
54% / Year
Estimated Growth
Estimates Accuracy
-44%
Average Miss

For the last 13 years the compound annual growth rate for Fuan Pharmaceutical Group Co Ltd's operating income is 10%. The projected CAGR for the next 2 years is 54%.

Net Income
Forecast

9% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-36%
Average Miss
9% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-36%
Average Miss

For the last 13 years the compound annual growth rate for Fuan Pharmaceutical Group Co Ltd's net income is 9%. The projected CAGR for the next 3 years is 1%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Fuan Pharmaceutical Group Co Ltd's stock price target?
Not Available

Fuan Pharmaceutical Group Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Fuan Pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
-3%

For the last 13 years the compound annual growth rate for Fuan Pharmaceutical Group Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is -3%.

What is Fuan Pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
54%

For the last 13 years the compound annual growth rate for Fuan Pharmaceutical Group Co Ltd's operating income is 10%. The projected CAGR for the next 2 years is 54%.

What is Fuan Pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
1%

For the last 13 years the compound annual growth rate for Fuan Pharmaceutical Group Co Ltd's net income is 9%. The projected CAGR for the next 3 years is 1%.

Back to Top